Lung Cancer
Weekly Paclitaxel Plus Carboplatin is Safe, Effective in Patients with Advanced Disease
Published in Cancer Weekly, September 26th, 2000
The use of Taxol (paclitaxel) plus Paraplatin (carboplatin), administered in a novel weekly regimen, offers a safe and effective treatment option for patients with advanced lung cancer, according to research presented September 13, 2000, at the 9th World Conference on Lung Cancer, held in Tokyo, Japan. Safety and tolerability are of critical importance in patients with advanced lung cancer.
"These data show that the use of weekly Taxol plus Paraplatin provides a very tolerable treatment for patients with advanced lung cancer," reported Chandra...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2000-09-26)
More Articles from Cancer Weekly
- Esophageal Cancer
Photodynamic Therapy Effective for Inoperable Tumors - Head and Neck Cancer
Chemotherapy/Radiotherapy Combination Effective for Short-Term Recurrent Tumor Control - Aflatoxins
Researchers Work to Combat Dangerous Fungal Compounds - Hepatocellular Carcinoma
Routine Follow-Up Improves Prospects for Long-Term Survival - Nasopharyngeal Cancer
Amyloidosis May be Indicative of Malignancy - Nasopharyngeal Cancer
Combination of Chemotherapy and Radiation Therapy is Effective for Children - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
